Proportion of isolates with resistance to azithromycin reported to in United States of America
United States of America: Proportion of isolates with resistance to azithromycin reported to was 5.8 in 2020. ◆ Volatile
Proportion of isolates with resistance to azithromycin reported to in United States of America, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
In 2020, proportion of isolates with resistance to azithromycin reported to in United States of America stood at 5.8. That is the highest value across all 11 years on record.
The figure is up 27.4% on the previous year and up 1,122.9% over ten years.
Over the whole period, proportion of isolates with resistance to azithromycin reported to in United States of America peaked at 5.8 in 2020 and was at its lowest, 0.2131, in 2009.
That places United States of America 26th out of 47 countries with data for 2020, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to azithromycin reported to in United States of America, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0.2131 | — |
| 2010 | 0.4743 | +122.5% |
| 2011 | 0.2927 | -38.3% |
| 2012 | 0.273 | -6.7% |
| 2013 | 0.5551 | +103.3% |
| 2014 | 2.43 | +338.6% |
| 2015 | 2.58 | +6.1% |
| 2016 | 3.61 | +39.9% |
| 2017 | 4.37 | +20.8% |
| 2018 | 4.55 | +4.3% |
| 2020 | 5.8 | +27.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.2131 | 0.2131 | 0.2131 | 1 |
| 2010s | 2.13 | 0.273 | 4.55 | 9 |
| 2020s | 5.8 | 5.8 | 5.8 | 1 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate 0.056 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0261 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1919 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to azithromycin reported to in United States of America?
- Proportion of isolates with resistance to azithromycin reported to in United States of America was 5.8 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to azithromycin reported to recorded in United States of America?
- The highest recorded value was 5.8 in 2020.
- What is the lowest proportion of isolates with resistance to azithromycin reported to recorded in United States of America?
- The lowest recorded value was 0.2131 in 2009.
- How does United States of America rank for proportion of isolates with resistance to azithromycin reported to?
- United States of America ranks 26th out of 47 countries with data for 2020.
- Is proportion of isolates with resistance to azithromycin reported to rising or falling in United States of America?
- Over the last ten years it is up 1,122.9%. The long-run trend across the full record is volatile.
- Where does this United States of America data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).